Las Vegas, NV -- (SBWIRE) -- 10/12/2012 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume movers as reported by http://beststocksdaily.com/
IDO Security, Inc. (OTC:IDOI) is currently trading at $0.260, 23.53% lower on a traded volume of 156K shares. IDO Security Inc. (IDO) is engaged in the design, development and marketing of devices for the homeland security and loss prevention markets that are intended for use in security screening procedures to detect metallic objects concealed on or in footwear, ankles and feet through the use of electro-magnetic fields.
To Get complete technical analysis on IDOI go to http://beststocksdaily.com/p2/index.php?company=IDOI
Provectus Pharmaceuticals, Inc.(OTC:PVCT) plunged 7.28% to $0.573 on a traded volume of 149K shares. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10.
Can PVCT Continue to Fall? Find Out Here http://beststocksdaily.com/p2/index.php?company=PVCT
A.P. Pharma, Inc. (OTC:APPA) fell 4.76% to $0.600 on a traded volume of 88K shares. A.P. Pharma, Inc. (A.P. Pharma) is a specialty pharmaceutical company developing pharmaceutical products using its Biochronomer polymer-based drug delivery technology.
To Get complete technical analysis on APPA go to http://beststocksdaily.com/p2/index.php?company=APPA
NeurogesX, Inc (OTC:NGSX) among the gainers and the stock added 3.57% to $0.290. NeurogesX Inc. NeurogesX), is a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pains management therapies to address unmet medical needs.
Get Free Trend Analysis on NGSX Here http://beststocksdaily.com/p2/index.php?company=NGSX
Cellceutix Corp (OTC:CTIX) among the gainers and the stock gained 1.94% to $1 on a traded volume of 14K shares. Cellceutix Corporation is an early-stage developmental biopharmaceutical company. The Company has acquired exclusive rights to eight different pharmaceutical compound candidates that are designed for treatment of diseases which exist, or may exist in the future.
Get Free Trend Analysis on CTIX Here http://beststocksdaily.com/p2/index.php?company=CTIX
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)